BRAF, another gene commonly altered in CRC, encodes a serine/threonine kinase involved in the mitogen-activated protein kinase (MAPK) signaling pathway, which regulates cellular proliferation, survival, differentiation, migration, and apoptosis. The gene discussed is MARK2; the disease is colorectal carcinoma.